+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

United States LYNPARZA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States LYNPARZA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
From
Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Elotuzumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Elotuzumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022 - Product Thumbnail Image

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

  • Clinical Trials
  • November 2022
  • 80 Pages
  • Global
From
Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 162 Pages
  • Global
From
From
Intratumoral Cancer Therapies - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intratumoral Cancer Therapies - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 144 Pages
  • Global
From
Peripheral T-Cell Lymphoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Peripheral T-Cell Lymphoma - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 117 Pages
  • Global
From
Myelofibrosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Myelofibrosis - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 110 Pages
  • Global
From
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
From
Oncolytic Virus Cancer Therapy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 160 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more